Internationalization and technological leapfrogging in the pharmaceutical industry

Suma Athreye () and Andrew Christopher Godley ()

Industrial and Corporate Change, 2009, vol. 18, issue 2, pages 295-323

Abstract: Internationalization is a useful strategy for gaining firm-specific technological advantages especially during periods of technological discontinuity as the pharmaceutical industry illustrates. The antibiotics revolution in the 1940s saw laggard US firms scrambling to gain capabilities in antibiotics. The possibilities of non-chemical routes to new drug discovery in the 1990s saw Indian generic drug manufacturers attempting to develop new drug discovery capabilities. This article compares the leapfrogging strategies adopted by US and Indian firms and shows that in both periods internationalization strategies were central to the technological strategies of both groups of firms. Copyright 2009 , Oxford University Press.

Date: 2009
View citations in EconPapers

Downloads: (external link)
http://hdl.handle.net/10.1093/icc/dtp002 (application/pdf)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:oup:indcch:v:18:y:2009:i:2:p:295-323

Ordering information: This journal article can be ordered from
http://www.oup.co.uk/journals

Access Statistics for this article

Industrial and Corporate Change is edited by David Teece, Glenn R. Carroll, Nick Von Tunzelmann, Giovanni Dosi and Franco Malerba

More articles in Industrial and Corporate Change from Oxford University Press
Address: Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, UK
Series data maintained by Christopher F. Baum ().